{"id":15195,"date":"2024-05-31T11:44:28","date_gmt":"2024-05-31T11:44:28","guid":{"rendered":"https:\/\/cansearch.ch\/?page_id=15195"},"modified":"2024-05-31T12:13:26","modified_gmt":"2024-05-31T12:13:26","slug":"4-relive-project-on-pediatric-liver-tumors","status":"publish","type":"page","link":"https:\/\/cansearch.ch\/en\/4-relive-project-on-pediatric-liver-tumors\/","title":{"rendered":"4.\tRELIVE &#8211; Project on pediatric liver tumors"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1456px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_5 1_5 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:20%;--awb-margin-top-large:0px;--awb-spacing-right-large:9.6%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:9.6%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:66.666666666667%;--awb-margin-top-large:0px;--awb-spacing-right-large:2.88%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:2.88%;--awb-width-medium:100%;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><h2><span style=\"color: #e05843;\">4. RELIVE &#8211; Project on liver tumors in children<\/span><\/h2>\n<h3>International Registry of Pediatric Patients with Recurrent or Refractory Hepatoblastoma or Hepatocellular Carcinoma.<\/h3>\n<p style=\"font-weight: 400;\"><a href=\"https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB.jpg\"><img decoding=\"async\" class=\"wp-image-9659 alignleft\" src=\"https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-1024x512.jpg\" alt=\"\" width=\"262\" height=\"131\" srcset=\"https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-200x100.jpg 200w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-300x150.jpg 300w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-400x200.jpg 400w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-500x250.jpg 500w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-540x272.jpg 540w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-600x300.jpg 600w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-700x350.jpg 700w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-768x384.jpg 768w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-800x400.jpg 800w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-1024x512.jpg 1024w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB-1200x600.jpg 1200w, https:\/\/cansearch.ch\/wp-content\/uploads\/2021\/02\/RELIVE_LogoTagline_Horizontal_RGB.jpg 1417w\" sizes=\"(max-width: 262px) 100vw, 262px\" \/><\/a><\/p>\n<p>The International Multicenter Registry aims to collect data on the health of children with refractory or recurrent liver tumors. Patients with hepatoblastoma (HB), hepatocellular carcinoma (HCC), and unspecified hepatocellular neoplasm (HCN NOS) refractory or recurrent currently have unsatisfactory long-term outcomes with current treatments. Additionally, there is no generally accepted treatment for these patients. The goal of the RELIVE research project is to obtain an overview of past approaches and recently applied therapeutic strategies specifically in this context and to study short- and long-term outcomes in these patients treated with these regimens. RELIVE aims to identify the most promising therapeutic approaches with the ultimate goal of developing a clinical trial testing these approaches.<\/p>\n<p>The RELIVE protocol was approved on September 21, 2020, by the Swiss Ethics Committee (CE). To date, RELIVE is active in 15 countries (Switzerland, Spain, France, Belgium, Netherlands, Poland, Germany, United Kingdom, Ireland, United States, Canada, Japan, Australia, New Zealand, and Hong Kong). A specific database, developed at the University Hospitals of Geneva (HUG), is used to collect data. Each active center has its own secure access and can enter the data of interest. As of May 2024, over 360 children from 15 countries and 64 hospitals have been enrolled in our international database. After an intense data verification period with each of the centers, the data analysis is ongoing.<\/p>\n<p>The RELIVE project has also been presented at the SIOP (International Society of Pediatric Oncology) and SIOPEL (International Society of Pediatric Oncology for Liver Cancer) congresses every year since spring 2021.<\/p>\n<p>[1] <a href=\"https:\/\/relive-international.net\/\" target=\"_new\" rel=\"noreferrer noopener\">https:\/\/relive-international.net<\/a><\/p>\n<\/div><div class=\"fusion-content-boxes content-boxes columns row fusion-columns-1 fusion-columns-total-1 fusion-content-boxes-1 content-boxes-icon-with-title content-left\" style=\"--awb-backgroundcolor:var(--awb-custom_color_2);--awb-body-color:var(--awb-color8);--awb-title-color:var(--awb-color8);--awb-hover-accent-color:#9e9e9e;--awb-circle-hover-accent-color:#9e9e9e;--awb-item-margin-bottom:40px;\" data-animationOffset=\"top-into-view\"><div style=\"--awb-backgroundcolor:var(--awb-custom_color_2);\" class=\"fusion-column content-box-column content-box-column content-box-column-1 col-lg-12 col-md-12 col-sm-12 fusion-content-box-hover content-box-column-last content-box-column-last-in-row\"><div class=\"col content-box-wrapper content-wrapper-background link-area-link-icon icon-hover-animation-fade\" data-animationOffset=\"top-into-view\"><div class=\"fusion-clearfix\"><\/div><div class=\"content-container\">\n<div>\n<div>\n<p class=\"Style3\"><span style=\"color: #000000;\"><em><b><span lang=\"FR-CH\">Qu\u2019apporte cette \u00e9tude aux patients&nbsp;?&nbsp;<\/span><\/b><\/em><\/span><\/p>\n<p class=\"Style3\"><span style=\"color: #000000;\"><em><span lang=\"FR-CH\">Le projet RELIVE permet d\u2019identifier les traitements les plus prometteurs pour am\u00e9liorer le pronostic des enfants atteints de tumeurs h\u00e9patiques r\u00e9fractaires ou r\u00e9cidivantes, mais aussi de mettre en place des \u00e9tudes scientifiques pour optimiser la compr\u00e9hension de ce cancer ainsi que sa prise en charge.<\/span><\/em><\/span><\/p>\n<\/div>\n<\/div>\n<\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":14,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"ngg_post_thumbnail":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-15195","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/pages\/15195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/comments?post=15195"}],"version-history":[{"count":2,"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/pages\/15195\/revisions"}],"predecessor-version":[{"id":15220,"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/pages\/15195\/revisions\/15220"}],"wp:attachment":[{"href":"https:\/\/cansearch.ch\/en\/wp-json\/wp\/v2\/media?parent=15195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}